Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ir.opgen.com/news-releases/news-release-details/opgen-announces-ce-ivd-marking-and-commercial-launch-europe-its
GAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that its subsidiary Curetis GmbH has obtained the CE mark certification in the European Union for its own SARS-CoV-2 Kit with PULB for the detection of SARS-CoV-2, the virus that causes COVID-19.
Developed and manufactured by Curetis’ team in Germany, the SARS-CoV-2 Kit with PULB uses real-time reverse transcription polymerase chain reaction (RT-PCR) technology for qualitative detection of the SARS-CoV-2 virus isolated from oropharyngeal and nasopharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider or for screening of asymptomatic individuals. This kit can be used with RNA isolated by performing standard RNA isolation processes, as well as with oropharyngeal or nasopharyngeal swabs collected in PCR compatible viral transport medium treated with PCR-Compatible Universal Lysis Buffer (PULB) provided in the kit. Including PULB in the kit as a workflow option allows labs to circumvent the need for extraction equipment and extraction kits/reagents, thereby providing operational and workflow efficiencies, time and cost savings. The kit is designed to provide time to results in approximately one hour, and it runs on open real-time PCR instruments such as the QuantStudio™ 5 Real-Time PCR System and the Bio-Rad CFX96™ Real-Time PCR Detection System.
“The CE-IVD Marking is an important step in advancing our efforts to support critical COVID-19 testing; the Curetis SARS-CoV-2 Kit with PULB provides additional testing capacity in countries that recognize the CE Mark to test patients,” said Johannes Bacher, COO of OpGen.
“By launching this new product in Europe, we are committed to helping our distributors and customers to expand the availability of SARS-CoV-2 diagnostic testing, and our own-developed CE-IVD marked SARS-CoV-2 Kit with PULB is expected to help increase availability of these much-needed tests," said Oliver Schacht, PhD, CEO of OpGen. “Our customers will benefit from an optimized workflow and a test that delivers great performance and significantly shorter time-to-result at favorable economics compared to many of the commercially available open PCR platform COVID-19 tests including the BGI SARS-CoV-2 kit. Having access to our own SARS-CoV-2 kit allows us to have that product distributed rather than the BGI test kit which we will cease distributing effective immediately.”
Major Pharmaceutical Giant will soon announce a definitive agreement to take over OpGen
https://www.issuewire.com/major-pharmaceutical-giant-will-soon-announce-a-definitive-agreement-to-take-over-opgen-1675356246555092
SCWorx to Resume Trading on Nasdaq Monday, August 10, 2020
https://ih.advfn.com/stock-market/NASDAQ/scworx-WORX/stock-news/83030078/scworx-to-resume-trading-on-nasdaq-monday-august
https://ih.advfn.com/stock-market/NASDAQ/scworx-WORX/stock-news/83030078/scworx-to-resume-trading-on-nasdaq-monday-august
And one 8K more
https://ih.advfn.com/stock-market/NASDAQ/scworx-WORX/stock-news/82522030/current-report-filing-8-k
On May 21, 2020, SCWorx Corp. (the “Company”) received a request for additional information/documents from the Nasdaq Stock Market. The Company expects to complete its response to this request on or before June 2, 2020.
Phunware Launches Next Generation Mobile Healthcare Solution at Parkview Health
https://finance.yahoo.com/news/phunware-launches-next-generation-mobile-123000691.html
Have you a link to this news ?
Tks
Annual report submitted late due to coronavirus
https://ih.advfn.com/stock-market/NASDAQ/scworx-WORX/stock-news/82460113/notification-that-annual-report-will-be-submitted
Item 8.01 Other Events.
Due to the impact of the COVID-19 coronavirus pandemic on the business, employees, consultants and service providers of Scworx, Corp., a Delaware corporation (the “Company”), the Company is unable to file its quarterly report on Form 10-Q for the quarter ended March 31, 2020 (the “Quarterly Report”) by the normally prescribed deadline of May 15, 2020. The Company plans to file its Quarterly Report by no later than June 29, 2020, 45 days after the original due date of its Quarterly Report, in reliance upon the exemption set forth in the Securities and Exchange Commission’s March 4, 2020 Order (Release No. 34-88318) (the “Order”), which under certain conditions exempts reporting companies form making certain filings required under the Securities and Exchange Act of 1934, as amended, for up to 45 after the normally prescribed deadline.
The Company’s operations and business have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and the world. The New York and New Jersey area, where the Company and its independent auditor are headquartered, is currently at one of the epicenters of the coronavirus outbreak in the United States. The Company has been following the recommendations of local health authorities to minimize exposure risk for its team members for the past several weeks, including the temporary closures of its offices and having team members work remotely, and, as a result, the Quarterly Report will not be completed by the filing deadline, due to insufficient time to facilitate the internal and external review process.
In addition, the Company’s customers (hospitals) have also experienced extraordinary disruptions to their businesses and supply chains, while experiencing unprecedented demand for health care services related to COVID-19. As a result of these extraordinary disruptions to our customers’ business, our customers are currently focused on meeting the nation’s health care needs in response to the COVID-19 pandemic. As a result, there is a continuing risk that our customers will not be able to focus resources on expanding the utilization of our services, which could adversely impact our future growth prospects, at least until the adverse effects of the pandemic subside. In addition, the financial impact of COVID-19 on our hospital customers may cause delayed payments due to us for services, which could negatively impact our cash flows. We are endeavoring to mitigate these risks and effects through the sale of personal protective equipment (“PPE”) and Covid-19 test kits to the health care industry and others, including many of our hospital customers. This is a new business for us and there is no assurance that we will be able to complete any sales of PPE/test kits or that any such sales will be sufficient to offset the negative effects of the COVID-19 pandemic on our business.
yes indeed
"May 13, 2020
UPDATE: On May 13, 2020 SCWorx Corp. submitted the information requested by Nasdaq stock market by its letter dated May 5, 2020."
OK tks
Have you an idea for this rise in premarket ?
Tks
Tks
Good news , hope remains
Tks but where did you find this information ?
In order for someone to be interested in the proposed financing, the share price must be higher than $ 5 because otherwise buying an action directly on the market costs less.
So the company will be forced to publish very quickly news to raise the price (The offering is expected to close on April 23, 2020)
https://ih.advfn.com/stock-market/NASDAQ/cyclacel-pharmaceuticals-CYCC/stock-news/82272623/cyclacel-announces-pricing-of-20-million-public-o
that's the real reason for this huge drop
scandalous masquerade
ok tks for your patience
do you think it will go up in a few days?
this should make the stock go up and not go down , no ?
I have tried but I haven't understood
can you tell me in a few words ?
Sorry I'm french and I don't understand such a down
thks but why such a down in premarket ?
What are consequences for CYCC ?
Thanks KeithPB57 this article confirms point buy point the PR of WORX
Now we just have to be a little patient
"KeithPB57 Friday, 04/17/20 10:53:22 PM
Here’s a great article that coincides with exactly what was said on the Conference Call.
https://www.google.com/amp/s/www.dailymail.co.uk/news/article-8145503/amp/COVID-19-Rapid-testing-kit-diagnoses-coronavirus-15-minutes-used-Australia-April-3.html
WORX is real!!!"
Here's a little reading that might give information to those who don't know
https://www.dailymail.co.uk/news/article-8145503/COVID-19-Rapid-testing-kit-diagnoses-coronavirus-15-minutes-used-Australia-April-3.html
Bravo for having found this article which perfectly corroborates the PR of WORX and which gives full credibility to what WORX announced
This will put a big kick in the buttocks of those who tried to shoot it down yesterday with an article laid in a timely manner to scare investors
I really hope so to have a better weekend
What's the matter ?
OK tks, I'm crossing fingers
Their dirty work will probably bear fruit today but hardly longer because it is based only on wind and fear
TKS man, very good job
Nothing for WORX
To imagine that in such a turbulent period the SEC received the 8K from WORX and did not make any unfavorable comments is to say that the SEC is useless or that they are incapable
Well no that is not my opinion, especially concerning a company listed on the Nasdaq
Sure it's a fake news
in France with Google
SCWorx news item deleted (NASDAQ:WORX) | Seeking Alphaseekingalpha.com › news › 356167...
Traduire cette page
Il y a 6 minutes - Seeking Alpha published a news item on SCWorx (NASDAQ:WORX) earlier this morning, with the title containing pejorative language.
I think too it's a fake news